Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.

NCT06971965 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

578

Enrollment

OTHER_GOV

Sponsor class

Conditions

Thyroid Cancer
Papillary Thyroid Carcinoma

Interventions

DRUG: Levothyroxin

Sponsor

National Cancer Center, Korea

Collaborators

[object Object]
[object Object]